Changing antibiotic prescribing practices in outpatient primary care settings in China: Study protocol for a health information system-based cluster-randomised crossover controlled trial

PLoS One. 2022 Jan 7;17(1):e0259065. doi: 10.1371/journal.pone.0259065. eCollection 2022.

Abstract

Background: The overuse and abuse of antibiotics is a major risk factor for antibiotic resistance in primary care settings of China. In this study, the effectiveness of an automatically-presented, privacy-protecting, computer information technology (IT)-based antibiotic feedback intervention will be evaluated to determine whether it can reduce antibiotic prescribing rates and unreasonable prescribing behaviours.

Methods: We will pilot and develop a cluster-randomised, open controlled, crossover, superiority trial. A total of 320 outpatient physicians in 6 counties of Guizhou province who met the standard will be randomly divided into intervention group and control group with a primary care hospital being the unit of cluster allocation. In the intervention group, the three components of the feedback intervention included: 1. Artificial intelligence (AI)-based real-time warnings of improper antibiotic use; 2. Pop-up windows of antibiotic prescription rate ranking; 3. Distribution of educational manuals. In the control group, no form of intervention will be provided. The trial will last for 6 months and will be divided into two phases of three months each. The two groups will crossover after 3 months. The primary outcome is the 10-day antibiotic prescription rate of physicians. The secondary outcome is the rational use of antibiotic prescriptions. The acceptability and feasibility of this feedback intervention study will be evaluated using both qualitative and quantitative assessment methods.

Discussion: This study will overcome limitations of our previous study, which only focused on reducing antibiotic prescription rates. AI techniques and an educational intervention will be used in this study to effectively reduce antibiotic prescription rates and antibiotic irregularities. This study will also provide new ideas and approaches for further research in this area.

Trial registration: ISRCTN, ID: ISRCTN13817256. Registered on 11 January 2020.

Publication types

  • Clinical Trial

MeSH terms

  • Ambulatory Care
  • Anti-Bacterial Agents / therapeutic use
  • Artificial Intelligence
  • China
  • Cluster Analysis
  • Controlled Clinical Trials as Topic / methods
  • Cross-Over Studies
  • Drug Resistance, Microbial
  • Health Information Systems
  • Humans
  • Inappropriate Prescribing / prevention & control*
  • Inappropriate Prescribing / statistics & numerical data
  • Inappropriate Prescribing / trends
  • Outpatients
  • Practice Patterns, Physicians' / statistics & numerical data
  • Practice Patterns, Physicians' / trends*
  • Primary Health Care / methods*
  • Primary Health Care / trends
  • Software

Substances

  • Anti-Bacterial Agents

Grants and funding

The study was funded by the National Natural Science Foundation of China Grant on “Research on feedback intervention mode of antibiotic prescription control in primary medical institutions based on the depth graph neural network technology” (71964009) and the Science and Technology Fund Project of Guizhou Provincial Health Commission Grant on “Application Research of Deep Learning Technology in Rational Evaluation and Intervention of Antibiotic Prescription” (gzwjkj2019-1-218). The funders had a role in the study which we should acknowledge. Specifically, all funders provided travel expenses during the data collection process, as well as the expert's expenses for providing guidance on the study design, technological guidance and data analysis.